Comparison of the central nervous system effects produced by six H1-receptor antagonists

Clinical and Experimental Allergy

Volumn 26, Issue 9, 1996, Pages 1092-1097

  Simons, F E R ^a,b   Fraser, T G ^a   Reggin, J D ^a   Simons, K J ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NONE   (Canada)

Author keywords

Antihistamine; Astemizole; Cetirizine; Diphenhydramine; H1 receptor antagonist; Ketotifen; Loratadine; P300; Terfenadine

Indexed keywords

ASTEMIZOLE; CETIRIZINE; DIPHENHYDRAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN; KETOTIFEN FUMARATE; LORATADINE; TERFENADINE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN TEST; SOMNOLENCE;

EID: 0029840126     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00649.x     Document Type: Article

References (24)

1. 1 antihistamines. Ann Allergy 1991; 67:625-33.
2. 1-receptor antagonists. Clin Exp Allergy 1994; 24:707-23.
3. 1-receptor antagonists. Comparative tolerability and safety. Drug Safety 1994; 10:350-80.
4. Rombaut NEI, Hindmarch I. Psychometric aspects of antihistamines: a review. Hum Psychopharmacol Clin Exp 1994; 9:157-69.
5. Simons FER, McMillan JL, Simons KJ. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine vs. placebo: suppressive effects on histamine-induced wheals and flares during 24 h in normal subjects. J Allergy Clin Immunol 1990; 86:540-7.
6. Polich J. P300 in clinical applications: meaning, method and measurement. Am J EEG Technol 1991; 31:201-31.
7. Meador KJ, Loring DW, Thompson EE, Thompson WO. Differential cognitive effects of terfenadine and chlorpheniramine. J Allergy Clin Immunol 1989; 84:322-5.
8. 1-receptor antagonists). Ann Allergy Asthma Immunol 1995; 75:507-14.
9. 1-receptor antagonists) terfenadine and chlorpheniramine in children. J Pediatr 1994; 124:979-83.
10. Simons FER, Fraser TG, Reggin JD, Roberts JR, Simons KJ. Adverse central nervous system effects of older antihistamines in children. Ped Allergy Immunol 1996; 7:22-7.
11. Roth T, Roehrs T, Koshorek G, Sicklesteel J, Zorick F. Sedative effects of antihistamines. J Allergy Clin Immunol 1987; 80:94-8.
12. Neter J, Wasserman W, Kutner MH. Applied Linear Statistical Models. 3rd Edn. Boston, MA: Irwin, 1990:517-67.
13. Marshall PS, Colon EA. Effects of allergy season on mood and cognitive function. Ann Allergy 1993; 71:251-8.
14. 1-antihistamine on the event-related potential (ERP) in normal volunteers. Psychopharmacology (Berl) 1989; 98:425-9.
15. O'Hanlon JF, Rumaekers JG. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94. Allergy 1995; 50:234-42.
16. Roehrs T, Zwyghuizen-Doorenbos A, Roth T. Sedative effects and plasma concentrations following single doses of triazolam, diphenhydramine, ethanol and placebo. Sleep 1993; 16:301-5.
17. Gengo F, Gabos C, Miller JK. The pharmacodynamics of diphenhydramine-induced drowsiness and changes in mental performance. Clin Pharmacol Ther 1989; 45:15-21.
18. 11C]Pyrilamine and positron emission tomography. J Neurochem 1992; 59:128-36.
19. 1 receptor activation reduces a background leakage potassium current. Neuroscience 1994; 59:579-88.
20. 1-blockers. In: Church MK, Rihoux J-P, eds. Therapeutic Index of Antihistamines. Lewiston, NY: Hogrefe & Huber, 1992:19-31.
21. Snyder SH, Snowman AM. Receptor effects of cetirizine. Ann Allergy 1987; 59:4-8.
22. Spencer CM, Faulds D, Peters DH. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993; 46:1055-80.
23. Falliers CJ, Brandon ML, Buchman E et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991; 66:257-62.
24. Grant SM, Goa KL, Fitton A, Sorkin EM. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 1990; 40:412-48.